Search - tctmd.com

Displaying 261 - 280 of 318

Sort: Relevancy | Date

News Conference News ESC 2019

ESC 2019: Antiplatelets in Diabetes, CAD and A-fib, an ARNI in HFpEF, Staged Complete PCI, and More

Shelley Wood

August 22, 2019

News Industry News

New study finds both components of blood pressure predict heart attack, stroke risk

July 17, 2019

News Conference News ESC Heart Failure 2019

Rivaroxaban Cuts Major Stroke Risk in COMMANDER HF Post Hoc Analysis

Shelley Wood

May 26, 2019

News Conference News HRS 2019

Cancer Survivors With Heart Failure Respond Well to CRT

Todd Neale

May 14, 2019

News Daily News

Elevations in hs-cTnI Linked to Higher Risk of CVD, Particularly Heart Failure

Michael O'Riordan

May 06, 2019

News Daily News

Mortality From Heart Failure Increasing in United States

Michael O'Riordan

May 06, 2019

News Daily News

Stem Cell Research—Shattered After Fabrication Scandal—Needs to Rebuild, Says EHJ Editor

Michael O'Riordan

April 12, 2019

News Daily News

Younger Type 2 Diabetes Patients Face Higher Mortality and CVD Risks

Michael O'Riordan

April 10, 2019

News Conference News ACC 2019

New DECLARE-TIMI 58 Data Shine a Light on Diabetes Patients Most Likely to Benefit From Dapagliflozin

Shelley Wood

March 26, 2019

News Conference News ACC 2019

Final MOMENTUM 3 Results Secure Superiority Claim for HeartMate 3 LVAD

Shelley Wood

March 22, 2019

News Daily News

How HF Drugs Help and Harm Female Patients: A Call for Sex-Specific Reporting

Shelley Wood

February 26, 2019

News Daily News

One in Two Americans Have Cardiovascular Disease: AHA Stats

Michael O'Riordan

February 04, 2019

News Daily News

Most Cardiovascular Drugs Can Be Safely Used in Pregnancy, Review Suggests

Todd Neale

February 01, 2019

News Daily News

‘Watchful Waiting’ Tied to Poor Long-term Outcomes in Patients With Severe AR, Analysis Suggests

L.A. McKeown

January 17, 2019

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for December 2018

Caitlin E. Cox

January 01, 2019

News Daily News

Data Hint at Unintended Consequences of Hospital Readmissions Reduction Program

L.A. McKeown

December 21, 2018

News Conference News AHA 2018

EMPA-HEART Offers Mechanistic Clues for Empagliflozin’s Cardiac Benefits

Michael O'Riordan

November 16, 2018

News Conference News AHA 2018

Canakinumab Reduces Heart-Failure Hospitalizations Among Responders: CANTOS Subanalysis

Caitlin E. Cox

November 13, 2018

News Conference News AHA 2018

DECLARE-TIMI 58 Supports HF Benefit of SGLT2 Inhibitors

Todd Neale

November 10, 2018

News Features

Country Roads: Vulnerable West Virginia Heart Patients Targeted in Outreach Program

Michael O'Riordan

October 29, 2018

Advertisement

ESC 2019: Antiplatelets in Diabetes, CAD and A-fib, an ARNI in HFpEF, Staged Complete PCI, and More

New study finds both components of blood pressure predict heart attack, stroke risk

Rivaroxaban Cuts Major Stroke Risk in COMMANDER HF Post Hoc Analysis

Cancer Survivors With Heart Failure Respond Well to CRT

Elevations in hs-cTnI Linked to Higher Risk of CVD, Particularly Heart Failure

Mortality From Heart Failure Increasing in United States

Stem Cell Research—Shattered After Fabrication Scandal—Needs to Rebuild, Says EHJ Editor

Younger Type 2 Diabetes Patients Face Higher Mortality and CVD Risks

New DECLARE-TIMI 58 Data Shine a Light on Diabetes Patients Most Likely to Benefit From Dapagliflozin

Final MOMENTUM 3 Results Secure Superiority Claim for HeartMate 3 LVAD

How HF Drugs Help and Harm Female Patients: A Call for Sex-Specific Reporting

One in Two Americans Have Cardiovascular Disease: AHA Stats

Most Cardiovascular Drugs Can Be Safely Used in Pregnancy, Review Suggests

‘Watchful Waiting’ Tied to Poor Long-term Outcomes in Patients With Severe AR, Analysis Suggests

TCTMD’s Top 10 Most Popular Stories for December 2018

Data Hint at Unintended Consequences of Hospital Readmissions Reduction Program

EMPA-HEART Offers Mechanistic Clues for Empagliflozin’s Cardiac Benefits

Canakinumab Reduces Heart-Failure Hospitalizations Among Responders: CANTOS Subanalysis

DECLARE-TIMI 58 Supports HF Benefit of SGLT2 Inhibitors

Country Roads: Vulnerable West Virginia Heart Patients Targeted in Outreach Program

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content